| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium ion binding | 5.01e-11 | 14 | 104 | 6 | GO:0031402 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 5.14e-11 | 26 | 104 | 7 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 3.65e-09 | 26 | 104 | 6 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium channel activity | 9.35e-09 | 52 | 104 | 7 | GO:0005272 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.57e-06 | 17 | 104 | 4 | GO:0099508 | |
| GeneOntologyMolecularFunction | chromatin binding | POLA1 KAT6A CHD2 BRD3 CBX4 MECP2 HP1BP3 H1-8 WDHD1 CHD5 KMT2A ASXL2 TAF1 CDCA5 STAG3 | 6.49e-06 | 739 | 104 | 15 | GO:0003682 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.16e-05 | 171 | 104 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | histone binding | 7.43e-05 | 265 | 104 | 8 | GO:0042393 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 7.69e-05 | 343 | 104 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 8.03e-05 | 44 | 104 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 2.66e-04 | 5 | 104 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 4.38e-04 | 68 | 104 | 4 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 4.63e-04 | 69 | 104 | 4 | GO:0016278 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 5.03e-04 | 30 | 104 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 5.16e-04 | 71 | 104 | 4 | GO:0042054 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 5.55e-04 | 31 | 104 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 6.61e-04 | 459 | 104 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 7.25e-04 | 465 | 104 | 9 | GO:0046873 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 7.35e-04 | 206 | 104 | 6 | GO:0140030 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 9.38e-04 | 37 | 104 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | unmethylated CpG binding | 1.18e-03 | 10 | 104 | 2 | GO:0045322 | |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 1.27e-03 | 41 | 104 | 3 | GO:0000217 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.27e-03 | 229 | 104 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.30e-03 | 230 | 104 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 1.36e-03 | 42 | 104 | 3 | GO:0140693 | |
| GeneOntologyMolecularFunction | channel activity | 1.69e-03 | 525 | 104 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | ABL1 GAS2L3 KAT6A BLNK HIP1R TAB2 BRD3 TDG CBX4 MECP2 SHANK2 NKD2 ARID5B EXOC7 PRDM16 YTHDF3 | 1.70e-03 | 1356 | 104 | 16 | GO:0060090 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.71e-03 | 526 | 104 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 2.02e-03 | 13 | 104 | 2 | GO:0046974 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 2.07e-03 | 103 | 104 | 4 | GO:0008276 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 2.22e-03 | 105 | 104 | 4 | GO:0008170 | |
| GeneOntologyMolecularFunction | zinc ion binding | ZCCHC9 CPXM2 POLA1 KAT6A TAB2 ZFAND4 RPH3A PRDM2 ZFHX4 KMT2A UBR3 TET3 | 2.30e-03 | 891 | 104 | 12 | GO:0008270 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.65e-03 | 182 | 104 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | ABL1 GAS2L3 KAT6A BLNK HIP1R BRD3 TDG CBX4 MECP2 SHANK2 ARID5B EXOC7 PRDM16 YTHDF3 | 2.74e-03 | 1160 | 104 | 14 | GO:0030674 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.77e-03 | 184 | 104 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | four-way junction DNA binding | 4.34e-03 | 19 | 104 | 2 | GO:0000400 | |
| GeneOntologyMolecularFunction | SUMO binding | 4.34e-03 | 19 | 104 | 2 | GO:0032183 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 4.80e-03 | 20 | 104 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 5.46e-03 | 627 | 104 | 9 | GO:0022890 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 4.67e-10 | 36 | 103 | 7 | GO:0086010 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 9.62e-09 | 121 | 103 | 9 | GO:0051899 | |
| GeneOntologyBiologicalProcess | chromatin organization | KAT6A RSF1 CHD2 BRD3 TDG CBX4 MECP2 PRDM2 HP1BP3 TASOR2 ZNF462 H1-8 WDHD1 CHD5 SETBP1 KMT2A TAF1 PRDM16 TET3 SPTY2D1 | 1.57e-08 | 896 | 103 | 20 | GO:0006325 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 2.47e-08 | 62 | 103 | 7 | GO:0086002 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | KAT6A RSF1 CHD2 BRD3 TDG MECP2 PRDM2 HP1BP3 TASOR2 H1-8 WDHD1 CHD5 SETBP1 KMT2A TAF1 PRDM16 TET3 SPTY2D1 | 2.54e-08 | 741 | 103 | 18 | GO:0006338 |
| GeneOntologyBiologicalProcess | neuronal action potential | 2.77e-08 | 63 | 103 | 7 | GO:0019228 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | KAT6A RSF1 CHD2 BRD3 TDG CBX4 MECP2 PRDM2 HP1BP3 TASOR2 ZNF462 H1-8 WDHD1 CHD5 SETBP1 KMT2A TAF1 PRDM16 TET3 SPTY2D1 | 9.41e-08 | 999 | 103 | 20 | GO:0071824 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 2.65e-07 | 87 | 103 | 7 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 4.20e-07 | 93 | 103 | 7 | GO:0086003 | |
| GeneOntologyBiologicalProcess | action potential | 7.54e-07 | 201 | 103 | 9 | GO:0001508 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.49e-06 | 112 | 103 | 7 | GO:0019226 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 3.45e-06 | 127 | 103 | 7 | GO:0070252 | |
| GeneOntologyBiologicalProcess | actin filament-based process | ROCK2 SCN11A ABL1 GAS2L3 CARMIL1 HIP1R SYNPO ARHGAP35 SCN1A SCN2A SCN3A SCN8A SCN9A SCN10A COBL FCHSD1 | 1.14e-05 | 912 | 103 | 16 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.18e-05 | 153 | 103 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.33e-05 | 217 | 103 | 8 | GO:0006941 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 1.89e-05 | 32 | 103 | 4 | GO:0048266 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 2.08e-05 | 167 | 103 | 7 | GO:0060048 | |
| GeneOntologyBiologicalProcess | muscle contraction | ROCK2 CACNA1S SCN11A CHRM2 SCN1A SCN2A SCN3A SCN8A SCN9A SCN10A | 3.19e-05 | 400 | 103 | 10 | GO:0006936 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 6.23e-05 | 43 | 103 | 4 | GO:0062149 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 7.92e-05 | 142 | 103 | 6 | GO:0034728 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 8.38e-05 | 208 | 103 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | muscle system process | ROCK2 CACNA1S SCN11A CMYA5 CHRM2 SCN1A SCN2A SCN3A SCN8A SCN9A SCN10A | 9.10e-05 | 547 | 103 | 11 | GO:0003012 |
| GeneOntologyBiologicalProcess | blood circulation | ROCK2 SCN11A ABL1 ARHGAP35 CHRM2 MECP2 SCN1A SCN2A SCN3A SCN8A SCN9A SCN10A | 9.40e-05 | 648 | 103 | 12 | GO:0008015 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | SCN11A ABL1 MECP2 KCNC1 SCN1A SCN2A SCN3A SCN8A SCN9A SCN10A KMT2A | 1.10e-04 | 559 | 103 | 11 | GO:0042391 |
| GeneOntologyBiologicalProcess | response to pain | 1.22e-04 | 51 | 103 | 4 | GO:0048265 | |
| GeneOntologyBiologicalProcess | heart contraction | 1.25e-04 | 298 | 103 | 8 | GO:0060047 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | ROCK2 ABL1 MAP6 CARMIL1 HIP1R SYNPO ARHGAP35 MECP2 CAMSAP1 SKA1 FCHSD1 | 1.50e-04 | 579 | 103 | 11 | GO:0051493 |
| GeneOntologyBiologicalProcess | response to potassium ion | 1.51e-04 | 21 | 103 | 3 | GO:0035864 | |
| GeneOntologyBiologicalProcess | heart process | 1.61e-04 | 309 | 103 | 8 | GO:0003015 | |
| GeneOntologyBiologicalProcess | sensory perception of pain | 1.83e-04 | 105 | 103 | 5 | GO:0019233 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 1.89e-04 | 57 | 103 | 4 | GO:0050974 | |
| GeneOntologyBiologicalProcess | epithelial tube formation | 2.33e-04 | 173 | 103 | 6 | GO:0072175 | |
| GeneOntologyBiologicalProcess | behavioral response to chemical pain | 2.45e-04 | 5 | 103 | 2 | GO:0061366 | |
| GeneOntologyBiologicalProcess | behavioral response to formalin induced pain | 2.45e-04 | 5 | 103 | 2 | GO:0061368 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 2.51e-04 | 330 | 103 | 8 | GO:0040029 | |
| GeneOntologyBiologicalProcess | neural tube closure | 2.58e-04 | 113 | 103 | 5 | GO:0001843 | |
| GeneOntologyBiologicalProcess | tube closure | 2.69e-04 | 114 | 103 | 5 | GO:0060606 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus involved in sensory perception of pain | 2.89e-04 | 26 | 103 | 3 | GO:0050965 | |
| GeneOntologyBiologicalProcess | circulatory system process | ROCK2 SCN11A ABL1 ARHGAP35 CHRM2 MECP2 SCN1A SCN2A SCN3A SCN8A SCN9A SCN10A | 2.94e-04 | 733 | 103 | 12 | GO:0003013 |
| GeneOntologyBiologicalProcess | primary neural tube formation | 3.41e-04 | 120 | 103 | 5 | GO:0014020 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | ROCK2 ABL1 CARMIL1 HIP1R SYNPO ARHGAP35 MECP2 CAMSAP1 FCHSD1 | 3.49e-04 | 438 | 103 | 9 | GO:1902903 |
| GeneOntologyBiologicalProcess | tube formation | 3.54e-04 | 187 | 103 | 6 | GO:0035148 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | 3.68e-04 | 122 | 103 | 5 | GO:0006334 | |
| GeneOntologyBiologicalProcess | positive regulation of actin filament bundle assembly | 3.95e-04 | 69 | 103 | 4 | GO:0032233 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 4.26e-04 | 126 | 103 | 5 | GO:0033555 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus involved in sensory perception | 4.45e-04 | 30 | 103 | 3 | GO:0050961 | |
| GeneOntologyBiologicalProcess | positive regulation of supramolecular fiber organization | 4.54e-04 | 196 | 103 | 6 | GO:1902905 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 4.62e-04 | 275 | 103 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | behavior | SCN11A ABL1 SYNPO MECP2 SHANK2 SCN1A SCN2A SCN3A SCN8A SCN9A SCN10A KMT2A UBR3 | 4.91e-04 | 891 | 103 | 13 | GO:0007610 |
| GeneOntologyBiologicalProcess | chemosensory behavior | 4.91e-04 | 31 | 103 | 3 | GO:0007635 | |
| GeneOntologyBiologicalProcess | associative learning | 4.92e-04 | 130 | 103 | 5 | GO:0008306 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 5.40e-04 | 32 | 103 | 3 | GO:0099505 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 5.43e-04 | 75 | 103 | 4 | GO:0050982 | |
| GeneOntologyBiologicalProcess | neural tube formation | 5.65e-04 | 134 | 103 | 5 | GO:0001841 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoskeleton organization | 5.75e-04 | 205 | 103 | 6 | GO:0051495 | |
| GeneOntologyBiologicalProcess | post-embryonic development | 5.84e-04 | 135 | 103 | 5 | GO:0009791 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus | 5.92e-04 | 33 | 103 | 3 | GO:0016048 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | ROCK2 ABL1 CARMIL1 HIP1R SYNPO ARHGAP35 MECP2 COBL SLX4 FCHSD1 | 6.65e-04 | 582 | 103 | 10 | GO:0044089 |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 6.73e-04 | 293 | 103 | 7 | GO:0032886 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 7.73e-04 | 300 | 103 | 7 | GO:0110053 | |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | 8.72e-04 | 222 | 103 | 6 | GO:0008154 | |
| GeneOntologyBiologicalProcess | sensory perception of temperature stimulus | 8.99e-04 | 38 | 103 | 3 | GO:0050951 | |
| GeneOntologyBiologicalProcess | actin filament organization | 1.02e-03 | 509 | 103 | 9 | GO:0007015 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 1.07e-03 | 231 | 103 | 6 | GO:0032271 | |
| GeneOntologyBiologicalProcess | embryonic epithelial tube formation | 1.22e-03 | 159 | 103 | 5 | GO:0001838 | |
| GeneOntologyBiologicalProcess | actin filament network formation | 1.32e-03 | 11 | 103 | 2 | GO:0051639 | |
| GeneOntologyBiologicalProcess | protein polymerization | 1.44e-03 | 334 | 103 | 7 | GO:0051258 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 1.51e-03 | 247 | 103 | 6 | GO:0009612 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.07e-12 | 17 | 103 | 7 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 8.19e-11 | 29 | 103 | 7 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | 2.47e-06 | 235 | 103 | 9 | GO:0034703 | |
| GeneOntologyCellularComponent | axon | SCN11A ABL1 MAP6 SYNPO CHRM2 SHANK2 KCNC1 SCN1A SCN2A SCN3A SCN8A SCN9A SCN10A COBL EXOC7 | 3.04e-05 | 891 | 103 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | nuclear body | REXO4 ABL1 CARMIL1 KAT6A ANKS1B TDG ZNF217 CBX4 CMYA5 VIRMA HP1BP3 PRCC SCN1A CHD5 SETBP1 | 3.55e-05 | 903 | 103 | 15 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear speck | REXO4 CARMIL1 KAT6A ZNF217 CBX4 CMYA5 VIRMA HP1BP3 PRCC CHD5 | 5.35e-05 | 431 | 103 | 10 | GO:0016607 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.06e-04 | 378 | 103 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | node of Ranvier | 1.25e-04 | 20 | 103 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | C-fiber | 1.43e-04 | 4 | 103 | 2 | GO:0044299 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1S SCN11A ABL1 MAP6 HIP1R ANKS1B SYNPO CHRM2 RPH3A SHANK2 KCNC1 SCN1A SCN3A SCN8A COBL FCHSD1 | 3.24e-04 | 1228 | 103 | 16 | GO:0036477 |
| GeneOntologyCellularComponent | axon initial segment | 3.87e-04 | 29 | 103 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | presynaptic membrane | 4.46e-04 | 277 | 103 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | actin cytoskeleton | ABL1 GAS2L3 CARMIL1 HIP1R SYNPO ARHGAP35 MPRIP COBL PEAK1 FCHSD1 | 5.54e-04 | 576 | 103 | 10 | GO:0015629 |
| GeneOntologyCellularComponent | synaptic membrane | SCN11A HIP1R CHRM2 RPH3A SHANK2 KCNC1 SCN1A SCN2A SCN8A SCN10A | 6.08e-04 | 583 | 103 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | neuronal cell body | SCN11A ABL1 HIP1R SYNPO CHRM2 SHANK2 KCNC1 SCN1A SCN3A SCN8A COBL FCHSD1 | 8.31e-04 | 835 | 103 | 12 | GO:0043025 |
| GeneOntologyCellularComponent | chromatin | FOXR1 POLA1 KAT6A RSF1 YY2 CHD2 BRD3 MECP2 ATF6B HP1BP3 H1-8 ZFHX4 CHD5 TAF1 CDCA5 STAG3 SLX4 | 8.77e-04 | 1480 | 103 | 17 | GO:0000785 |
| GeneOntologyCellularComponent | main axon | 9.85e-04 | 89 | 103 | 4 | GO:0044304 | |
| GeneOntologyCellularComponent | dendrite | CACNA1S ABL1 MAP6 HIP1R ANKS1B SYNPO CHRM2 RPH3A SHANK2 KCNC1 SCN8A COBL | 1.05e-03 | 858 | 103 | 12 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CACNA1S ABL1 MAP6 HIP1R ANKS1B SYNPO CHRM2 RPH3A SHANK2 KCNC1 SCN8A COBL | 1.07e-03 | 860 | 103 | 12 | GO:0097447 |
| GeneOntologyCellularComponent | transmembrane transporter complex | 1.12e-03 | 523 | 103 | 9 | GO:1902495 | |
| GeneOntologyCellularComponent | dendritic spine | 1.27e-03 | 242 | 103 | 6 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 1.41e-03 | 247 | 103 | 6 | GO:0044309 | |
| GeneOntologyCellularComponent | transporter complex | 1.59e-03 | 550 | 103 | 9 | GO:1990351 | |
| GeneOntologyCellularComponent | cell body | SCN11A ABL1 HIP1R SYNPO CHRM2 SHANK2 KCNC1 SCN1A SCN3A SCN8A COBL FCHSD1 | 2.05e-03 | 929 | 103 | 12 | GO:0044297 |
| GeneOntologyCellularComponent | PcG protein complex | 2.15e-03 | 52 | 103 | 3 | GO:0031519 | |
| GeneOntologyCellularComponent | glutamatergic synapse | ROCK2 SCN11A HIP1R ANKS1B SYNPO CHRM2 MECP2 SHANK2 SCN2A SCN8A SCN10A | 2.30e-03 | 817 | 103 | 11 | GO:0098978 |
| GeneOntologyCellularComponent | presynapse | ROCK2 SCN11A ANKS1B CHRM2 RPH3A SHANK2 KCNC1 SCN1A SCN2A SCN8A SCN10A | 4.27e-03 | 886 | 103 | 11 | GO:0098793 |
| GeneOntologyCellularComponent | postsynapse | ROCK2 CACNA1S ABL1 HIP1R ANKS1B SYNPO CHRM2 MECP2 RPH3A SHANK2 KCNC1 SCN8A | 4.31e-03 | 1018 | 103 | 12 | GO:0098794 |
| HumanPheno | Simple febrile seizure | 2.11e-06 | 27 | 42 | 5 | HP:0011171 | |
| HumanPheno | Allodynia | 5.15e-06 | 5 | 42 | 3 | HP:0012533 | |
| HumanPheno | Complex febrile seizure | 6.77e-06 | 16 | 42 | 4 | HP:0011172 | |
| HumanPheno | Autistic behavior | POLA1 KAT6A CHD2 MECP2 ZNF462 SCN1A CHD5 SCN2A SETBP1 SCN3A SCN8A SCN9A KMT2A CC2D2A TAF1 PRDM16 TET3 | 1.05e-05 | 678 | 42 | 17 | HP:0000729 |
| HumanPheno | Visually-induced seizure | 1.12e-05 | 18 | 42 | 4 | HP:0020216 | |
| HumanPheno | Multifocal epileptiform discharges | 1.37e-05 | 66 | 42 | 6 | HP:0010841 | |
| HumanPheno | Infection-related seizure | 1.85e-05 | 145 | 42 | 8 | HP:0032892 | |
| HumanPheno | Seizure precipitated by febrile infection | 1.85e-05 | 145 | 42 | 8 | HP:0032894 | |
| HumanPheno | Febrile seizure (within the age range of 3 months to 6 years) | 1.85e-05 | 145 | 42 | 8 | HP:0002373 | |
| HumanPheno | Reflex seizure | 2.62e-05 | 22 | 42 | 4 | HP:0020207 | |
| HumanPheno | Photosensitive myoclonic seizure | 2.84e-05 | 8 | 42 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 2.84e-05 | 8 | 42 | 3 | HP:0200048 | |
| HumanPheno | Diagnostic behavioral phenotype | POLA1 KAT6A CHD2 MECP2 ZNF462 SCN1A CHD5 SCN2A SETBP1 SCN3A SCN8A SCN9A KMT2A CC2D2A TAF1 PRDM16 TET3 | 3.87e-05 | 747 | 42 | 17 | HP:0025783 |
| HumanPheno | Focal hemiclonic seizure | 4.46e-05 | 25 | 42 | 4 | HP:0006813 | |
| HumanPheno | Lack of peer relationships | 6.01e-05 | 10 | 42 | 3 | HP:0002332 | |
| HumanPheno | Abnormal peer relationships | 6.01e-05 | 10 | 42 | 3 | HP:5200016 | |
| HumanPheno | Erythromelalgia | 6.01e-05 | 10 | 42 | 3 | HP:0032147 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 6.11e-05 | 27 | 42 | 4 | HP:0031475 | |
| HumanPheno | Neonatal seizure | 8.22e-05 | 11 | 42 | 3 | HP:0032807 | |
| HumanPheno | Limited neck range of motion | 8.22e-05 | 11 | 42 | 3 | HP:0000466 | |
| HumanPheno | Abnormal calvaria morphology | SFRP4 ABL1 SCARF2 POLA1 TRAIP KAT6A MECP2 ZNF462 PIK3CD SCN1A CHD5 SETBP1 SCN3A SCN8A SCN9A KMT2A CC2D2A TAF1 CAMSAP1 PRDM16 TET3 SLX4 | 9.39e-05 | 1254 | 42 | 22 | HP:0002683 |
| HumanPheno | Epilepsia partialis continua | 1.09e-04 | 12 | 42 | 3 | HP:0012847 | |
| HumanPheno | Focal automatism seizure | 1.09e-04 | 12 | 42 | 3 | HP:0032898 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 1.41e-04 | 13 | 42 | 3 | HP:0007058 | |
| HumanPheno | Generalized clonic seizure | 1.55e-04 | 34 | 42 | 4 | HP:0011169 | |
| HumanPheno | Generalized tonic seizure | 1.59e-04 | 64 | 42 | 5 | HP:0010818 | |
| HumanPheno | Deformed tarsal bones | 1.74e-04 | 35 | 42 | 4 | HP:0008119 | |
| HumanPheno | Generalized myoclonic seizure | 1.74e-04 | 148 | 42 | 7 | HP:0002123 | |
| HumanPheno | Disturbance of facial expression | 1.94e-04 | 36 | 42 | 4 | HP:0005324 | |
| HumanPheno | Nasolacrimal duct obstruction | 1.94e-04 | 36 | 42 | 4 | HP:0000579 | |
| HumanPheno | Interictal epileptiform activity | CHD2 MECP2 KCNC1 SCN1A SCN2A SETBP1 SCN3A SCN8A SCN9A CAMSAP1 | 1.96e-04 | 319 | 42 | 10 | HP:0011182 |
| HumanPheno | Abnormal curvature of the vertebral column | GDF5 CACNA1S SFRP4 ABL1 POLA1 TRAIP AK9 MECP2 PIK3CD SCN1A SCN2A SETBP1 SCN9A KMT2A CC2D2A ASXL2 TAF1 CAMSAP1 PRG4 PRDM16 SLX4 | 2.07e-04 | 1219 | 42 | 21 | HP:0010674 |
| HumanPheno | Myoclonic seizure | 2.19e-04 | 262 | 42 | 9 | HP:0032794 | |
| HumanPheno | Facial tics | 2.21e-04 | 15 | 42 | 3 | HP:0011468 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 2.21e-04 | 15 | 42 | 3 | HP:0007207 | |
| HumanPheno | Interictal EEG abnormality | CHD2 MECP2 KCNC1 SCN1A SCN2A SETBP1 SCN3A SCN8A SCN9A CAMSAP1 | 2.28e-04 | 325 | 42 | 10 | HP:0025373 |
| HumanPheno | Dysgenesis of the hippocampus | 2.71e-04 | 16 | 42 | 3 | HP:0025101 | |
| HumanPheno | Abnormal relationship | 2.71e-04 | 16 | 42 | 3 | HP:5200024 | |
| HumanPheno | EEG with generalized epileptiform discharges | 2.75e-04 | 270 | 42 | 9 | HP:0011198 | |
| HumanPheno | Focal motor status epilepticus | 3.27e-04 | 17 | 42 | 3 | HP:0032663 | |
| HumanPheno | Atypical absence status epilepticus | 3.27e-04 | 17 | 42 | 3 | HP:0011151 | |
| HumanPheno | Focal clonic seizure | 3.56e-04 | 42 | 42 | 4 | HP:0002266 | |
| HumanPheno | EEG with focal epileptiform discharges | 3.61e-04 | 118 | 42 | 6 | HP:0011185 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 3.90e-04 | 18 | 42 | 3 | HP:0032860 | |
| HumanPheno | Lacrimal duct stenosis | 4.61e-04 | 19 | 42 | 3 | HP:0007678 | |
| HumanPheno | Clonic seizure | 4.82e-04 | 81 | 42 | 5 | HP:0020221 | |
| HumanPheno | Atypical absence seizure | 5.07e-04 | 46 | 42 | 4 | HP:0007270 | |
| HumanPheno | Abnormal external nose morphology | SCARF2 TRAIP KAT6A CHD2 MECP2 ZNF462 PIK3CD SCN1A CHD5 SCN2A SETBP1 KMT2A CC2D2A ASXL2 TAF1 PRDM16 SLX4 | 5.16e-04 | 916 | 42 | 17 | HP:0010938 |
| HumanPheno | Non-convulsive status epilepticus without coma | 5.39e-04 | 20 | 42 | 3 | HP:0032671 | |
| HumanPheno | Psychomotor deterioration | 5.39e-04 | 20 | 42 | 3 | HP:0002361 | |
| HumanPheno | Pes planus | 5.82e-04 | 365 | 42 | 10 | HP:0001763 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 6.21e-04 | 368 | 42 | 10 | HP:0031432 | |
| HumanPheno | Talipes valgus | 6.25e-04 | 21 | 42 | 3 | HP:0004684 | |
| HumanPheno | Dysesthesia | 6.25e-04 | 21 | 42 | 3 | HP:0012534 | |
| HumanPheno | Infantile sensorineural hearing impairment | 6.53e-04 | 5 | 42 | 2 | HP:0008610 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 6.53e-04 | 5 | 42 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 6.53e-04 | 5 | 42 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 6.53e-04 | 5 | 42 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 6.53e-04 | 5 | 42 | 2 | HP:0032823 | |
| HumanPheno | Focal head nodding automatism seizure | 6.53e-04 | 5 | 42 | 2 | HP:0032906 | |
| HumanPheno | Aggressive behavior | POLA1 CHD2 MECP2 SCN1A CHD5 SCN2A SETBP1 SCN3A SCN8A SCN9A KMT2A PRDM16 | 6.59e-04 | 516 | 42 | 12 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | POLA1 CHD2 MECP2 SCN1A CHD5 SCN2A SETBP1 SCN3A SCN8A SCN9A KMT2A PRDM16 | 6.59e-04 | 516 | 42 | 12 | HP:0006919 |
| HumanPheno | Short attention span | POLA1 CHD2 SCN1A CHD5 SCN2A SETBP1 SCN3A SCN8A SCN9A KMT2A TAF1 TET3 | 6.71e-04 | 517 | 42 | 12 | HP:0000736 |
| HumanPheno | Abnormal lacrimal duct morphology | 6.99e-04 | 50 | 42 | 4 | HP:0011481 | |
| HumanPheno | EEG with spike-wave complexes | 7.06e-04 | 88 | 42 | 5 | HP:0010850 | |
| HumanPheno | EEG with abnormally slow frequencies | 7.06e-04 | 88 | 42 | 5 | HP:0011203 | |
| HumanPheno | Perseverative thought | 7.52e-04 | 377 | 42 | 10 | HP:0030223 | |
| HumanPheno | Reduced attention regulation | POLA1 CHD2 SCN1A CHD5 SCN2A SETBP1 SCN3A SCN8A SCN9A KMT2A TAF1 TET3 | 7.85e-04 | 526 | 42 | 12 | HP:5200044 |
| HumanPheno | Bilateral tonic-clonic seizure with generalized onset | 8.12e-04 | 52 | 42 | 4 | HP:0025190 | |
| HumanPheno | Tibial torsion | 8.23e-04 | 23 | 42 | 3 | HP:0100694 | |
| HumanPheno | Tonic seizure | 8.98e-04 | 140 | 42 | 6 | HP:0032792 | |
| HumanPheno | Disordered formal thought process | 9.04e-04 | 386 | 42 | 10 | HP:0025769 | |
| HumanPheno | Abnormality of cranial sutures | SCARF2 POLA1 TRAIP KAT6A ZNF462 CHD5 SETBP1 SCN9A CAMSAP1 PRDM16 | 9.41e-04 | 388 | 42 | 10 | HP:0011329 |
| HumanPheno | Normal interictal EEG | 9.75e-04 | 6 | 42 | 2 | HP:0002372 | |
| HumanPheno | Long face | 1.05e-03 | 259 | 42 | 8 | HP:0000276 | |
| HumanPheno | Pes valgus | 1.08e-03 | 56 | 42 | 4 | HP:0008081 | |
| HumanPheno | EEG abnormality | CHD2 MECP2 KCNC1 SCN1A SCN2A SETBP1 SCN3A SCN8A SCN9A CAMSAP1 PRDM16 TET3 | 1.13e-03 | 548 | 42 | 12 | HP:0002353 |
| HumanPheno | Impulsivity | 1.24e-03 | 149 | 42 | 6 | HP:0100710 | |
| HumanPheno | Abnormal thought pattern | 1.29e-03 | 404 | 42 | 10 | HP:5200269 | |
| HumanPheno | Status epilepticus | 1.33e-03 | 207 | 42 | 7 | HP:0002133 | |
| HumanPheno | Abnormal morphology of the nasal alae | SCARF2 KAT6A CHD2 MECP2 ZNF462 PIK3CD SCN1A SCN2A SETBP1 KMT2A CC2D2A ASXL2 TAF1 | 1.33e-03 | 639 | 42 | 13 | HP:0000429 |
| HumanPheno | Limited knee extension | 1.33e-03 | 27 | 42 | 3 | HP:0003066 | |
| HumanPheno | Hyperactivity | POLA1 CHD2 MECP2 SCN1A CHD5 SCN2A SETBP1 SCN3A SCN8A KMT2A TAF1 TET3 | 1.33e-03 | 558 | 42 | 12 | HP:0000752 |
| HumanPheno | Anteverted nares | KAT6A CHD2 MECP2 ZNF462 PIK3CD SCN1A SCN2A SETBP1 KMT2A CC2D2A ASXL2 TAF1 | 1.35e-03 | 559 | 42 | 12 | HP:0000463 |
| HumanPheno | Upturned nose | KAT6A CHD2 MECP2 ZNF462 PIK3CD SCN1A SCN2A SETBP1 KMT2A CC2D2A ASXL2 TAF1 | 1.35e-03 | 559 | 42 | 12 | HP:0000427 |
| HumanPheno | Eyelid myoclonia seizure | 1.36e-03 | 7 | 42 | 2 | HP:0032678 | |
| HumanPheno | Generalized hypertrichosis | 1.36e-03 | 7 | 42 | 2 | HP:0004554 | |
| HumanPheno | Focal aware seizure | 1.48e-03 | 28 | 42 | 3 | HP:0002349 | |
| HumanPheno | Abnormality of tear glands or tear production | 1.58e-03 | 156 | 42 | 6 | HP:0000521 | |
| HumanPheno | Abnormal blood vessel morphology | SCN11A ABL1 POLA1 TRAIP KAT6A TAB2 ZNF462 PIK3CD SCN1A CFAP221 SCN2A SETBP1 SCN9A SCN10A KMT2A ASXL2 SEC63 PRDM16 SLX4 | 1.60e-03 | 1201 | 42 | 19 | HP:0033353 |
| HumanPheno | Rigidity | 1.61e-03 | 214 | 42 | 7 | HP:0002063 | |
| HumanPheno | Status epilepticus with prominent motor symptoms | 1.64e-03 | 29 | 42 | 3 | HP:0032658 | |
| HumanPheno | Pain insensitivity | 1.64e-03 | 29 | 42 | 3 | HP:0007021 | |
| HumanPheno | EEG with generalized slow activity | 1.64e-03 | 29 | 42 | 3 | HP:0010845 | |
| HumanPheno | Limb myoclonus | 1.64e-03 | 29 | 42 | 3 | HP:0045084 | |
| HumanPheno | Abnormal tibia morphology | 1.71e-03 | 107 | 42 | 5 | HP:0002992 | |
| HumanPheno | Abnormality of the forehead | ABL1 KAT6A CHD2 ZNF462 PIK3CD SCN1A CHD5 SCN2A SETBP1 SCN3A SCN8A KMT2A CC2D2A ASXL2 TAF1 CAMSAP1 PRDM16 TET3 SLX4 | 1.72e-03 | 1208 | 42 | 19 | HP:0000290 |
| HumanPheno | Abnormal nostril morphology | KAT6A CHD2 MECP2 ZNF462 PIK3CD SCN1A SCN2A SETBP1 KMT2A CC2D2A ASXL2 TAF1 | 1.73e-03 | 575 | 42 | 12 | HP:0005288 |
| HumanPheno | Broad nasal tip | 1.74e-03 | 159 | 42 | 6 | HP:0000455 | |
| MousePheno | abnormal action potential | 1.73e-05 | 133 | 86 | 7 | MP:0005402 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | ABL1 GAS2L3 MAP6 ANKS1B TAB2 CHD2 ARHGAP35 HP1BP3 SHANK2 SCN1A ARID5B SCN8A SCN9A KMT2A CC2D2A UBR3 ASXL2 CAMSAP1 SLX4 | 4.13e-05 | 1124 | 86 | 19 | MP:0011112 |
| MousePheno | abnormal synaptic transmission | ROCK2 SCN11A MAP6 RSF1 HIP1R ANKS1B SYNPO CHD2 CMYA5 PRAG1 CHRM2 MECP2 TASOR2 SHANK2 SCN1A SCN2A SCN8A SCN9A | 7.30e-05 | 1070 | 86 | 18 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | ROCK2 SCN11A MAP6 RSF1 HIP1R ANKS1B SYNPO CHD2 CMYA5 PRAG1 CHRM2 MECP2 TASOR2 SHANK2 SCN1A SCN2A SCN8A SCN9A | 7.84e-05 | 1076 | 86 | 18 | MP:0021009 |
| MousePheno | abnormal CNS synaptic transmission | ROCK2 SCN11A MAP6 RSF1 HIP1R ANKS1B SYNPO CHD2 CMYA5 PRAG1 CHRM2 MECP2 TASOR2 SHANK2 SCN1A SCN2A SCN9A | 8.78e-05 | 985 | 86 | 17 | MP:0002206 |
| MousePheno | decreased chondrocyte number | 9.70e-05 | 15 | 86 | 3 | MP:0000167 | |
| MousePheno | abnormal pro-B cell morphology | 1.16e-04 | 78 | 86 | 5 | MP:0005432 | |
| Domain | Na_channel_asu | 1.49e-14 | 10 | 103 | 7 | IPR001696 | |
| Domain | Na_trans_assoc | 1.49e-14 | 10 | 103 | 7 | IPR010526 | |
| Domain | Na_trans_assoc | 1.49e-14 | 10 | 103 | 7 | PF06512 | |
| Domain | Channel_four-helix_dom | 2.39e-11 | 57 | 103 | 9 | IPR027359 | |
| Domain | - | 2.39e-11 | 57 | 103 | 9 | 1.20.120.350 | |
| Domain | Na_trans_cytopl | 2.76e-11 | 6 | 103 | 5 | PF11933 | |
| Domain | Na_trans_cytopl | 2.76e-11 | 6 | 103 | 5 | IPR024583 | |
| Domain | Ion_trans_dom | 1.33e-08 | 114 | 103 | 9 | IPR005821 | |
| Domain | Ion_trans | 1.33e-08 | 114 | 103 | 9 | PF00520 | |
| Domain | IQ_motif_EF-hand-BS | 1.04e-05 | 90 | 103 | 6 | IPR000048 | |
| Domain | IQ | 1.26e-05 | 93 | 103 | 6 | PS50096 | |
| Domain | H15 | 4.48e-05 | 13 | 103 | 3 | SM00526 | |
| Domain | H15 | 4.48e-05 | 13 | 103 | 3 | PS51504 | |
| Domain | IQ | 4.51e-05 | 71 | 103 | 5 | PF00612 | |
| Domain | Histone_H1/H5_H15 | 5.67e-05 | 14 | 103 | 3 | IPR005818 | |
| Domain | IQ | 8.50e-05 | 81 | 103 | 5 | SM00015 | |
| Domain | AT_hook | 8.66e-05 | 16 | 103 | 3 | PF02178 | |
| Domain | ZF_PHD_2 | 1.81e-04 | 95 | 103 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 1.90e-04 | 96 | 103 | 5 | PS01359 | |
| Domain | Chromo_domain | 3.03e-04 | 24 | 103 | 3 | IPR023780 | |
| Domain | Chromo | 3.86e-04 | 26 | 103 | 3 | PF00385 | |
| Domain | AT_hook | 4.33e-04 | 27 | 103 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 4.33e-04 | 27 | 103 | 3 | IPR017956 | |
| Domain | CHROMO_1 | 4.83e-04 | 28 | 103 | 3 | PS00598 | |
| Domain | CHROMO_2 | 4.83e-04 | 28 | 103 | 3 | PS50013 | |
| Domain | Chromodomain-like | 7.19e-04 | 32 | 103 | 3 | IPR016197 | |
| Domain | PHD | 7.85e-04 | 75 | 103 | 4 | PF00628 | |
| Domain | Chromo/shadow_dom | 7.88e-04 | 33 | 103 | 3 | IPR000953 | |
| Domain | CHROMO | 7.88e-04 | 33 | 103 | 3 | SM00298 | |
| Domain | Znf_PHD-finger | 9.54e-04 | 79 | 103 | 4 | IPR019787 | |
| Domain | Znf_FYVE_PHD | 1.33e-03 | 147 | 103 | 5 | IPR011011 | |
| Domain | PHD | 1.49e-03 | 89 | 103 | 4 | SM00249 | |
| Domain | BROMODOMAIN_2 | 1.49e-03 | 41 | 103 | 3 | PS50014 | |
| Domain | BROMO | 1.60e-03 | 42 | 103 | 3 | SM00297 | |
| Domain | Bromodomain | 1.60e-03 | 42 | 103 | 3 | IPR001487 | |
| Domain | - | 1.60e-03 | 42 | 103 | 3 | 1.20.920.10 | |
| Domain | Znf_PHD | 1.61e-03 | 91 | 103 | 4 | IPR001965 | |
| Domain | SET | 2.08e-03 | 46 | 103 | 3 | SM00317 | |
| Domain | Linker_histone | 2.26e-03 | 13 | 103 | 2 | PF00538 | |
| Domain | SET_dom | 2.65e-03 | 50 | 103 | 3 | IPR001214 | |
| Domain | SET | 2.65e-03 | 50 | 103 | 3 | PS50280 | |
| Domain | - | 3.40e-03 | 449 | 103 | 8 | 3.30.40.10 | |
| Domain | C345C | 3.88e-03 | 17 | 103 | 2 | SM00643 | |
| Domain | Znf_RING/FYVE/PHD | 3.89e-03 | 459 | 103 | 8 | IPR013083 | |
| Domain | Chromodomain_CS | 4.35e-03 | 18 | 103 | 2 | IPR023779 | |
| Domain | NTR | 4.84e-03 | 19 | 103 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 4.84e-03 | 19 | 103 | 2 | IPR018933 | |
| Domain | EF-hand-dom_pair | 5.15e-03 | 287 | 103 | 6 | IPR011992 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.15e-10 | 31 | 75 | 7 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.74e-10 | 32 | 75 | 7 | M27455 | |
| Pathway | WP_DRAVET_SYNDROME | 3.33e-07 | 28 | 75 | 5 | M45519 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.53e-06 | 121 | 75 | 7 | M872 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | SCN11A ABL1 MECP2 SHANK2 PIK3CD SCN1A SCN2A SCN3A SCN8A SCN9A SCN10A | 3.53e-06 | 367 | 75 | 11 | M48346 |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 5.69e-06 | 130 | 75 | 7 | M27454 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | ROCK2 CACNA1S SCN11A ABL1 ARHGAP35 UPF2 PIK3CD SCN1A SCN2A SCN3A SCN8A SCN9A SCN10A | 9.35e-06 | 575 | 75 | 13 | M29853 |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.00e-04 | 203 | 75 | 7 | M5485 | |
| Pathway | WP_RETT_SYNDROME | 1.20e-04 | 48 | 75 | 4 | M39759 | |
| Pubmed | 6.68e-17 | 9 | 105 | 7 | 16382098 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 6.55e-16 | 6 | 105 | 6 | 23652591 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZCCHC9 REXO4 POLA1 KAT6A RSF1 SYNPO CHD2 BRD3 CBX4 SRBD1 MECP2 PRDM2 HP1BP3 ZNF462 GTF3C2 CHD5 KMT2A TAF1 | 3.55e-13 | 608 | 105 | 18 | 36089195 |
| Pubmed | 1.10e-12 | 13 | 105 | 6 | 15123669 | ||
| Pubmed | 7.84e-11 | 4 | 105 | 4 | 17537961 | ||
| Pubmed | 7.84e-11 | 4 | 105 | 4 | 35031483 | ||
| Pubmed | 7.84e-11 | 4 | 105 | 4 | 29578003 | ||
| Pubmed | 3.91e-10 | 5 | 105 | 4 | 8812438 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 3.91e-10 | 5 | 105 | 4 | 22875929 | |
| Pubmed | 1.17e-09 | 6 | 105 | 4 | 16029194 | ||
| Pubmed | 1.17e-09 | 6 | 105 | 4 | 23711479 | ||
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 2.73e-09 | 7 | 105 | 4 | 24440715 | |
| Pubmed | 5.44e-09 | 8 | 105 | 4 | 25101983 | ||
| Pubmed | Genetic mapping of the peripheral sodium channel genes, Scn9a and Scn10a, in the mouse. | 9.77e-09 | 9 | 105 | 4 | 8854872 | |
| Pubmed | 9.77e-09 | 9 | 105 | 4 | 15746173 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | ZNF217 PRDM2 ZNF462 ZFHX4 ARID5B KMT2A ASXL2 TAF1 PRDM16 SLX4 YTHDF3 | 1.01e-08 | 351 | 105 | 11 | 38297188 |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.07e-08 | 139 | 105 | 8 | 16985003 | |
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 19284629 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 12610651 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 32005694 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 33895391 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 23859570 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 19699781 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 18784617 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 17544618 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 32845893 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 28518218 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 38999942 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 17928448 | ||
| Pubmed | Yield of peripheral sodium channels gene screening in pure small fibre neuropathy. | 2.67e-08 | 3 | 105 | 3 | 30554136 | |
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 14973256 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 15302875 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 3.81e-08 | 12 | 105 | 4 | 30175250 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 9.11e-08 | 341 | 105 | 10 | 32971831 | |
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 21156207 | ||
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 22260870 | ||
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 35801810 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 1.07e-07 | 4 | 105 | 3 | 8974318 | |
| Pubmed | GAS2L3 MAP6 TAB2 CHD2 TACC2 TTC3 PRDM2 WDHD1 PIK3CD ARID5B ASXL2 PEAK1 SEC63 SPTY2D1 SLX4 YTHDF3 | 1.65e-07 | 1084 | 105 | 16 | 11544199 | |
| Pubmed | 2.66e-07 | 5 | 105 | 3 | 1679748 | ||
| Pubmed | 2.66e-07 | 5 | 105 | 3 | 17724025 | ||
| Pubmed | Pain-causing stinging nettle toxins target TMEM233 to modulate NaV1.7 function. | 2.66e-07 | 5 | 105 | 3 | 37117223 | |
| Pubmed | 2.66e-07 | 5 | 105 | 3 | 24337656 | ||
| Pubmed | REXO4 YY2 ZNF217 PRDM2 HP1BP3 MPRIP ZNF462 GTF3C2 ZFHX4 PRCC CHD5 ARID5B KMT2A ASXL2 TAF1 PRDM16 SLX4 YTHDF3 | 2.70e-07 | 1429 | 105 | 18 | 35140242 | |
| Pubmed | ROCK2 SCN11A NHSL2 RSF1 ANKS1B SYNPO CHD2 BRD3 SRBD1 TTC3 MECP2 HP1BP3 TASOR2 SHANK2 CHD5 SCN9A KMT2A CC2D2A | 3.08e-07 | 1442 | 105 | 18 | 35575683 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ABL1 CARMIL1 TAB2 CBX4 PRAG1 VIRMA MPRIP NHSL1 NKD2 KMT2A COBL PEAK1 CAMSAP1 FAM110B | 3.34e-07 | 861 | 105 | 14 | 36931259 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ZCCHC9 REXO4 TRAIP KAT6A RPP38 TACC2 SRBD1 VIRMA HP1BP3 GTF3C2 UPF2 EXOC7 SPTY2D1 | 5.08e-07 | 759 | 105 | 13 | 35915203 |
| Pubmed | ZCCHC9 REXO4 RPP38 HIP1R CHD2 BRD3 ZNF217 CBX4 SRBD1 VIRMA MECP2 MPRIP SHANK2 GTF3C2 KMT2A OS9 SEC63 SPTY2D1 | 5.30e-07 | 1497 | 105 | 18 | 31527615 | |
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 16386788 | ||
| Pubmed | Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? | 5.31e-07 | 6 | 105 | 3 | 17513486 | |
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 9143501 | ||
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 17928439 | ||
| Pubmed | 7.39e-07 | 103 | 105 | 6 | 32744500 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 9.28e-07 | 7 | 105 | 3 | 25818041 | |
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 23575686 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABL1 KAT6A HIP1R ARHGAP35 TTC3 PRAG1 MPRIP NHSL1 SHANK2 PIK3CD CHD5 SCN8A COBL CAMSAP1 PRDM16 | 1.19e-06 | 1105 | 105 | 15 | 35748872 |
| Pubmed | GAS2L3 POLA1 KAT6A RSF1 TAB2 SYNPO ARHGAP35 MECP2 NHSL1 NKD2 WDHD1 ASXL2 | 1.21e-06 | 689 | 105 | 12 | 36543142 | |
| Pubmed | ROCK2 MAP6 CARMIL1 ANKS1B SYNPO ARHGAP35 VIRMA MECP2 RPH3A HP1BP3 MPRIP NHSL1 SHANK2 UPF2 SCN2A KMT2A PEAK1 | 1.34e-06 | 1431 | 105 | 17 | 37142655 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CARMIL1 KAT6A BLNK SYNPO CHD2 ARHGAP35 TTC3 HP1BP3 TASOR2 ZNF462 SHANK2 SETBP1 ARID5B COBL OS9 TET3 PRKX | 2.30e-06 | 1489 | 105 | 17 | 28611215 |
| Pubmed | 5.77e-06 | 12 | 105 | 3 | 8169823 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | REXO4 RSF1 YY2 CBX4 MECP2 HP1BP3 TASOR2 PRCC KMT2A TAF1 CDCA5 SLX4 YTHDF3 | 6.25e-06 | 954 | 105 | 13 | 36373674 |
| Pubmed | ROCK2 MAP6 NHSL2 ANKS1B SYNPO TTC3 VIRMA ATF6B RPH3A MPRIP ZNF462 SHANK2 CAMSAP1 | 6.91e-06 | 963 | 105 | 13 | 28671696 | |
| Pubmed | 7.38e-06 | 153 | 105 | 6 | 10718198 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RPP38 CHD2 BRD3 CBX4 SRBD1 MECP2 PRDM2 HP1BP3 GTF3C2 ARID5B KMT2A ASXL2 CDCA5 TET3 SPTY2D1 | 8.07e-06 | 1294 | 105 | 15 | 30804502 |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 29649454 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 35563063 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 20346423 | ||
| Pubmed | Heat-resistant action potentials require TTX-resistant sodium channels NaV1.8 and NaV1.9. | 9.03e-06 | 2 | 105 | 2 | 29970412 | |
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 9.03e-06 | 2 | 105 | 2 | 37901435 | |
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 9.03e-06 | 2 | 105 | 2 | 26410685 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 18399542 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 24144460 | ||
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 9.03e-06 | 2 | 105 | 2 | 10827969 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 33783941 | ||
| Pubmed | Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases. | 9.03e-06 | 2 | 105 | 2 | 27531744 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 19694741 | ||
| Pubmed | Specificity of MLL1 and TET3 CXXC domains towards naturally occurring cytosine modifications. | 9.03e-06 | 2 | 105 | 2 | 30352306 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 35348308 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 9.03e-06 | 2 | 105 | 2 | 11245985 | |
| Pubmed | Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. | 9.03e-06 | 2 | 105 | 2 | 16111501 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 15760941 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 9.03e-06 | 2 | 105 | 2 | 1317301 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 9.03e-06 | 2 | 105 | 2 | 23016767 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 27153334 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 33096315 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 9.03e-06 | 2 | 105 | 2 | 24990319 | |
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 9.03e-06 | 2 | 105 | 2 | 25172946 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 31439038 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 30866959 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 28450535 | ||
| Pubmed | Sodium channel expression within chronic multiple sclerosis plaques. | 9.03e-06 | 2 | 105 | 2 | 17805013 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 26311622 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 33411788 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 19931571 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 31943325 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 34930944 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 16857712 | ||
| Pubmed | Structure of SgK223 pseudokinase reveals novel mechanisms of homotypic and heterotypic association. | 9.03e-06 | 2 | 105 | 2 | 29079850 | |
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 9.03e-06 | 2 | 105 | 2 | 15249644 | |
| Pubmed | An embryonic CaVβ1 isoform promotes muscle mass maintenance via GDF5 signaling in adult mouse. | 9.03e-06 | 2 | 105 | 2 | 31694926 | |
| Interaction | SCN11A interactions | 9.57e-09 | 15 | 104 | 5 | int:SCN11A | |
| Interaction | CENPA interactions | REXO4 KAT6A RSF1 BRD3 SRBD1 VIRMA MECP2 PRDM2 HP1BP3 ZNF462 GTF3C2 KMT2A TAF1 | 7.36e-08 | 377 | 104 | 13 | int:CENPA |
| Interaction | CACNA1D interactions | 1.31e-07 | 24 | 104 | 5 | int:CACNA1D | |
| Interaction | H3C1 interactions | ROCK2 REXO4 POLA1 KAT6A RSF1 WDR46 BRD3 CBX4 SRBD1 VIRMA MECP2 PRDM2 HP1BP3 GTF3C2 KMT2A TAF1 CAMSAP1 PRDM16 CDCA5 | 1.56e-07 | 901 | 104 | 19 | int:H3C1 |
| Interaction | H3C3 interactions | ZCCHC9 REXO4 RSF1 BRD3 CBX4 SRBD1 MECP2 PRDM2 HP1BP3 ZNF462 GTF3C2 CHD5 KMT2A TAF1 | 2.55e-07 | 495 | 104 | 14 | int:H3C3 |
| Interaction | H3-3A interactions | REXO4 POLA1 KAT6A RSF1 SYNPO CHD2 BRD3 CBX4 SRBD1 MECP2 PRDM2 HP1BP3 GTF3C2 CHD5 KMT2A TAF1 CDCA5 | 2.74e-07 | 749 | 104 | 17 | int:H3-3A |
| Interaction | H2BC8 interactions | REXO4 POLA1 RSF1 BRD3 CBX4 SRBD1 VIRMA MECP2 HP1BP3 GTF3C2 PRCC ARID5B KMT2A CDCA5 | 1.55e-06 | 576 | 104 | 14 | int:H2BC8 |
| Interaction | NUP43 interactions | REXO4 POLA1 RSF1 RPP38 VIRMA MECP2 PRDM2 HP1BP3 TASOR2 ZNF462 KMT2A ASXL2 CDCA5 SLX4 | 4.00e-06 | 625 | 104 | 14 | int:NUP43 |
| Interaction | SCN5A interactions | 4.29e-06 | 47 | 104 | 5 | int:SCN5A | |
| Interaction | SNRNP40 interactions | REXO4 POLA1 KAT6A RSF1 RPP38 ZNF217 SRBD1 VIRMA MECP2 TASOR2 ZNF462 PRCC KMT2A SPTY2D1 | 4.98e-06 | 637 | 104 | 14 | int:SNRNP40 |
| Interaction | CBX3 interactions | REXO4 RSF1 BRD3 ZNF217 VIRMA MECP2 HP1BP3 ZNF462 PRCC CHD5 KMT2A ASXL2 PRDM16 SLX4 | 5.85e-06 | 646 | 104 | 14 | int:CBX3 |
| Interaction | NEDD4L interactions | 6.18e-06 | 320 | 104 | 10 | int:NEDD4L | |
| Interaction | SCN4B interactions | 7.34e-06 | 8 | 104 | 3 | int:SCN4B | |
| Interaction | SCN1A interactions | 1.44e-05 | 29 | 104 | 4 | int:SCN1A | |
| Interaction | ZNF330 interactions | REXO4 RSF1 RPP38 BRD3 SRBD1 VIRMA MECP2 HP1BP3 KMT2A TAF1 SPTY2D1 | 1.94e-05 | 446 | 104 | 11 | int:ZNF330 |
| Interaction | MEN1 interactions | REXO4 POLA1 WDR46 RPP38 CBX4 SRBD1 HP1BP3 ZNF462 GTF3C2 WDHD1 UPF2 PRCC SETBP1 KMT2A COBL TAF1 YTHDF3 | 1.97e-05 | 1029 | 104 | 17 | int:MEN1 |
| Interaction | CTTN interactions | ABL1 NHSL2 HIP1R SYNPO CBX4 ARHGAP35 MECP2 MPRIP SHANK2 PEAK1 YTHDF3 | 2.10e-05 | 450 | 104 | 11 | int:CTTN |
| Interaction | SCN10A interactions | 2.14e-05 | 11 | 104 | 3 | int:SCN10A | |
| Interaction | CDKL5 interactions | 2.64e-05 | 113 | 104 | 6 | int:CDKL5 | |
| Interaction | YWHAZ interactions | ABL1 MAP6 KAT6A RSF1 HIP1R TAB2 SYNPO BRD3 TACC2 CBX4 VIRMA MPRIP NHSL1 NKD2 PRCC KMT2A ASXL2 PEAK1 CAMSAP1 | 4.03e-05 | 1319 | 104 | 19 | int:YWHAZ |
| Interaction | RPS6 interactions | ROCK2 ZCCHC9 REXO4 KAT6A RSF1 WDR46 RPP38 BRD3 VIRMA MECP2 HP1BP3 H1-8 UPF2 SPTY2D1 SLX4 | 4.15e-05 | 874 | 104 | 15 | int:RPS6 |
| Interaction | NALCN interactions | 4.66e-05 | 14 | 104 | 3 | int:NALCN | |
| Interaction | YWHAH interactions | ABL1 NHSL2 CARMIL1 TAB2 CBX4 PRAG1 VIRMA RPH3A MPRIP NHSL1 NKD2 KMT2A CC2D2A COBL PEAK1 CAMSAP1 FAM110B | 4.67e-05 | 1102 | 104 | 17 | int:YWHAH |
| Interaction | TMSB4Y interactions | 4.79e-05 | 39 | 104 | 4 | int:TMSB4Y | |
| Interaction | EHMT1 interactions | 5.45e-05 | 188 | 104 | 7 | int:EHMT1 | |
| Interaction | FGFBP1 interactions | 5.63e-05 | 257 | 104 | 8 | int:FGFBP1 | |
| Interaction | TOP1 interactions | POLA1 TRAIP KAT6A RSF1 BRD3 CBX4 VIRMA MECP2 HP1BP3 GTF3C2 KMT2A PRDM16 SPTY2D1 | 6.05e-05 | 696 | 104 | 13 | int:TOP1 |
| Interaction | KLF12 interactions | 6.64e-05 | 194 | 104 | 7 | int:KLF12 | |
| Interaction | PHIP interactions | 7.32e-05 | 197 | 104 | 7 | int:PHIP | |
| Interaction | FEV interactions | 8.83e-05 | 203 | 104 | 7 | int:FEV | |
| Interaction | TAF3 interactions | 9.27e-05 | 88 | 104 | 5 | int:TAF3 | |
| Interaction | PSIP1 interactions | 9.39e-05 | 205 | 104 | 7 | int:PSIP1 | |
| Interaction | PARP1 interactions | REXO4 ABL1 POLA1 TRAIP RSF1 BRD3 CBX4 SRBD1 VIRMA MECP2 PRDM2 HP1BP3 GTF3C2 WDHD1 ASXL2 PRDM16 STAG3 SLX4 | 1.28e-04 | 1316 | 104 | 18 | int:PARP1 |
| Interaction | H3C14 interactions | 1.59e-04 | 156 | 104 | 6 | int:H3C14 | |
| Interaction | SCN9A interactions | 1.66e-04 | 21 | 104 | 3 | int:SCN9A | |
| Interaction | BRCA2 interactions | 1.68e-04 | 384 | 104 | 9 | int:BRCA2 | |
| Interaction | KDM5B interactions | 1.70e-04 | 100 | 104 | 5 | int:KDM5B | |
| Interaction | RBBP4 interactions | VIRMA MECP2 ZNF462 WDHD1 CHD5 BEND7 ARID5B KMT2A ASXL2 PRDM16 CDCA5 | 1.82e-04 | 573 | 104 | 11 | int:RBBP4 |
| Interaction | H1-6 interactions | 1.86e-04 | 229 | 104 | 7 | int:H1-6 | |
| Interaction | SET interactions | 2.10e-04 | 311 | 104 | 8 | int:SET | |
| Interaction | TAF4B interactions | 2.19e-04 | 23 | 104 | 3 | int:TAF4B | |
| Interaction | POLR1G interactions | 2.20e-04 | 489 | 104 | 10 | int:POLR1G | |
| Interaction | HSF2BP interactions | 2.44e-04 | 318 | 104 | 8 | int:HSF2BP | |
| Interaction | H2BC21 interactions | ROCK2 SFRP4 KAT6A RSF1 CBX4 SRBD1 VIRMA MECP2 PRDM2 HP1BP3 KMT2A CDCA5 | 2.48e-04 | 696 | 104 | 12 | int:H2BC21 |
| Interaction | KIF2A interactions | 2.61e-04 | 242 | 104 | 7 | int:KIF2A | |
| Interaction | ARHGEF19 interactions | 2.61e-04 | 60 | 104 | 4 | int:ARHGEF19 | |
| Interaction | TLX1 interactions | 2.96e-04 | 175 | 104 | 6 | int:TLX1 | |
| Interaction | HP1BP3 interactions | 3.07e-04 | 329 | 104 | 8 | int:HP1BP3 | |
| Interaction | AFF4 interactions | 3.25e-04 | 115 | 104 | 5 | int:AFF4 | |
| Interaction | CHD4 interactions | REXO4 KAT6A RSF1 BRD3 VIRMA MECP2 HP1BP3 ZNF462 ZFHX4 WDHD1 CHD5 KMT2A PRDM16 SLX4 | 3.27e-04 | 938 | 104 | 14 | int:CHD4 |
| Interaction | TSPYL1 interactions | 3.38e-04 | 116 | 104 | 5 | int:TSPYL1 | |
| Interaction | CAPZA2 interactions | 3.87e-04 | 430 | 104 | 9 | int:CAPZA2 | |
| Interaction | BTBD17 interactions | 3.90e-04 | 6 | 104 | 2 | int:BTBD17 | |
| Interaction | RRP8 interactions | 3.93e-04 | 259 | 104 | 7 | int:RRP8 | |
| Interaction | CSNK2A1 interactions | KAT6A RSF1 BRD3 ZNF217 CBX4 SRBD1 MECP2 HP1BP3 PRCC BEND7 KMT2A ASXL2 TAF1 PRDM16 | 3.96e-04 | 956 | 104 | 14 | int:CSNK2A1 |
| Interaction | PPP2R2C interactions | 4.00e-04 | 67 | 104 | 4 | int:PPP2R2C | |
| Interaction | ZNF462 interactions | 4.23e-04 | 68 | 104 | 4 | int:ZNF462 | |
| Interaction | SMARCA2 interactions | 4.29e-04 | 346 | 104 | 8 | int:SMARCA2 | |
| Cytoband | Xq13.1 | 1.87e-04 | 48 | 105 | 3 | Xq13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 2.15e-04 | 127 | 105 | 4 | chr2q24 | |
| Cytoband | 2q24 | 2.81e-04 | 11 | 105 | 2 | 2q24 | |
| Cytoband | 2q24.3 | 6.09e-04 | 16 | 105 | 2 | 2q24.3 | |
| Cytoband | 3p22.2 | 1.38e-03 | 24 | 105 | 2 | 3p22.2 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.49e-16 | 9 | 67 | 7 | 1203 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.68e-04 | 34 | 67 | 3 | 487 | |
| GeneFamily | PHD finger proteins | 3.46e-04 | 90 | 67 | 4 | 88 | |
| GeneFamily | Zinc fingers CXXC-type | 8.72e-04 | 12 | 67 | 2 | 136 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.77e-03 | 17 | 67 | 2 | 486 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 1.77e-03 | 17 | 67 | 2 | 1197 | |
| Coexpression | HADDAD_B_LYMPHOCYTE_PROGENITOR | BLNK HIP1R PRDM2 TASOR2 PIK3CD SCN3A ARID5B KMT2A COBL STAG3 | 2.69e-07 | 290 | 105 | 10 | M939 |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 1.18e-06 | 194 | 105 | 8 | M7467 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MAP6 ANKS1B CBX4 ARHGAP35 TTC3 PRDM2 ZNF462 SHANK2 ZFHX4 KCNC1 PIK3CD SCN1A CHD5 SCN2A SCN3A SCN8A SCN9A | 1.86e-06 | 1106 | 105 | 17 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | MAP6 CBX4 ZNF462 SHANK2 ZFHX4 KCNC1 PIK3CD SCN1A CHD5 SCN2A SCN3A SCN8A SCN9A | 4.82e-06 | 703 | 105 | 13 | M39070 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.84e-10 | 191 | 105 | 9 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.00e-10 | 194 | 105 | 9 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-09 | 198 | 105 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-09 | 198 | 105 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-08 | 194 | 105 | 8 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.10e-08 | 195 | 105 | 8 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.36e-08 | 198 | 105 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-Memory_B_cells|Lung / Manually curated celltypes from each tissue | 1.69e-07 | 171 | 105 | 7 | 9ecef653f6916572bf5fbee5aea6c577d04e96ba | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.44e-07 | 190 | 105 | 7 | a7498fe55b7810c482291db782dc5282675d246a | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.69e-07 | 192 | 105 | 7 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.24e-07 | 196 | 105 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-07 | 196 | 105 | 7 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.39e-07 | 197 | 105 | 7 | 5c67ed18fb92aec73c79f4db6d80cec777d9ba44 | |
| ToppCell | severe-B_memory|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.54e-07 | 198 | 105 | 7 | 88649dc642193bda5e8eff3f79c832807d5e200a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.54e-07 | 198 | 105 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.54e-07 | 198 | 105 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.70e-07 | 199 | 105 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.70e-07 | 199 | 105 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 4.86e-07 | 200 | 105 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.37e-06 | 172 | 105 | 6 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.23e-06 | 179 | 105 | 6 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-06 | 179 | 105 | 6 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.37e-06 | 180 | 105 | 6 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 4.37e-06 | 180 | 105 | 6 | 237a2130a3f48595dad2417539c21e44585962b8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.37e-06 | 180 | 105 | 6 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.96e-06 | 184 | 105 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-06 | 186 | 105 | 6 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-06 | 186 | 105 | 6 | 08632045d499e61dd96ff29a5a9a208afe58dc58 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.28e-06 | 186 | 105 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 187 | 105 | 6 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 187 | 105 | 6 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 187 | 105 | 6 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 187 | 105 | 6 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-06 | 188 | 105 | 6 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | normal-na-Lymphocytic_B-B_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.61e-06 | 188 | 105 | 6 | ec72ba73b10c6f2ff39699b6b46b90a3e95a4c24 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.61e-06 | 188 | 105 | 6 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.61e-06 | 188 | 105 | 6 | 0ddc5dbe2fd905fee20c33d9845629e259faacd9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-06 | 188 | 105 | 6 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 189 | 105 | 6 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 5.78e-06 | 189 | 105 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 189 | 105 | 6 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-06 | 189 | 105 | 6 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.96e-06 | 190 | 105 | 6 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.14e-06 | 191 | 105 | 6 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.33e-06 | 192 | 105 | 6 | 446c61c0d6ba89c619efe87ee495951299953981 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-B_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.33e-06 | 192 | 105 | 6 | 0bda96d8f223e8fa9caf935079ab202fc5c812ee | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-06 | 192 | 105 | 6 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.33e-06 | 192 | 105 | 6 | 800edadd1d1ba6b7e0a0398030dd4b61c9c480c7 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-B_lymphocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.52e-06 | 193 | 105 | 6 | ddc06227f2580774d9f34729dff912d6a9155f9c | |
| ToppCell | COVID_non-vent-Lymphocytic-B_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.52e-06 | 193 | 105 | 6 | 32d139f922cd19adc1cc1e0e9a828115be9945d6 | |
| ToppCell | COVID_non-vent-Lymphocytic-B_cell-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.52e-06 | 193 | 105 | 6 | 91955c3773c9729a96e82f240f06b072367970d9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-06 | 193 | 105 | 6 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.72e-06 | 194 | 105 | 6 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.72e-06 | 194 | 105 | 6 | 9b134a6e51b8556a04c362967fa474f8a7f59920 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-06 | 195 | 105 | 6 | d2c9c58b46bf96f9a536e177b995e340b55c6750 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.92e-06 | 195 | 105 | 6 | 0c49d22c348aec6d8a1a976e7c88d0a3b48a4244 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 7.12e-06 | 196 | 105 | 6 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 7.12e-06 | 196 | 105 | 6 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.12e-06 | 196 | 105 | 6 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.12e-06 | 196 | 105 | 6 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.33e-06 | 197 | 105 | 6 | 3fe665c0277d091290b63f0dd24c0c6536a45309 | |
| ToppCell | COVID-19_Severe-Lymphoid_B|COVID-19_Severe / Disease group, lineage and cell class | 7.33e-06 | 197 | 105 | 6 | 25303329b051831cf2ed4df68f3948308e5fbd96 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.33e-06 | 197 | 105 | 6 | 368a7908435cb0d0feea135345e7179584a1e0cf | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.55e-06 | 198 | 105 | 6 | 71e847e8c24744d6df4a960348ad2ecf310373b4 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.77e-06 | 199 | 105 | 6 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.77e-06 | 199 | 105 | 6 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.77e-06 | 199 | 105 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-06 | 199 | 105 | 6 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-B_memory|Influenza_Severe / Disease, condition lineage and cell class | 7.77e-06 | 199 | 105 | 6 | bf0285f68c9cb1417fc070abc3cb224d07407e0e | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.99e-06 | 200 | 105 | 6 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | severe-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.99e-06 | 200 | 105 | 6 | 0e86f52b6e146d9bbc728d8fb176fc2b53696558 | |
| ToppCell | mild-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.99e-06 | 200 | 105 | 6 | 222789b897e2a683bbfd1d00b6fd8705015d90df | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B|Influenza_Severe / Disease, condition lineage and cell class | 7.99e-06 | 200 | 105 | 6 | bf238a0a074d6c5cba8cb73d3b715ee701a612b6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Intermediate|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 9.69e-06 | 120 | 105 | 5 | eb5b88c47dd4a6f9b55ace24f19d4e81d4ed31e1 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.05e-05 | 122 | 105 | 5 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.84e-05 | 150 | 105 | 5 | d9931507257c64ead4a53786e6822f51962c6015 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.33e-05 | 155 | 105 | 5 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 163 | 105 | 5 | 5efecdd8a069a822bc9d35b407092925a865e629 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 163 | 105 | 5 | 0d94a427f86e62aba12c397c6d7b8cd297f3a0e5 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.36e-05 | 164 | 105 | 5 | 0662cd9d21608efacc336e0a582859f3b9a4951d | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.36e-05 | 164 | 105 | 5 | b92e7c91910d518627376166c6ea9ed333b3d07e | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.36e-05 | 164 | 105 | 5 | a1e43c6b3e2553f5604100db6e92bf244b70c36d | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.61e-05 | 166 | 105 | 5 | 8de8f388f24436b84e19ef460476fdbda4d16abf | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 4.88e-05 | 168 | 105 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.88e-05 | 168 | 105 | 5 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-05 | 169 | 105 | 5 | 0332f539a2f7d6dcd081a5d2f567290721f5a329 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B-Naive_B_cells|blood / Manually curated celltypes from each tissue | 5.46e-05 | 172 | 105 | 5 | f16f90d17feac1ee52fd513907b28456865fd31d | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.93e-05 | 175 | 105 | 5 | a84965d28438a4228d841b357c2cd75cf4b59a63 | |
| ToppCell | COVID-matDC-|COVID / Condition, Cell_class and T cell subcluster | 5.93e-05 | 175 | 105 | 5 | db5e170411dfa62074c4b8311bb8c589d1c4279b | |
| ToppCell | COVID-matDC|COVID / Condition, Cell_class and T cell subcluster | 5.93e-05 | 175 | 105 | 5 | e2b638109c9ffd10430e6e134035622b7605ce23 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-B_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.26e-05 | 177 | 105 | 5 | d4db058c09012ec9fbde61277a9f86d9956de8fc | |
| ToppCell | NS-moderate-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.26e-05 | 177 | 105 | 5 | 174c54acfe19e2bb31418d69e228032ba724cbb6 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-B_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.26e-05 | 177 | 105 | 5 | 320fd77c7c98e9305dcc34a168ec9d674539ed65 | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.43e-05 | 178 | 105 | 5 | 499640cfb1063aa40343ec1563e40fe4645466fb | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.43e-05 | 178 | 105 | 5 | 851fdcf1451880a048885cc6677b4edfff6aee4c | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.43e-05 | 178 | 105 | 5 | 1a3b3b73e81ceb26cec8153cd1bdd7b446887a71 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-05 | 179 | 105 | 5 | dcaf2191134a586d50ebaf67dcf5b815b54a722b | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-05 | 179 | 105 | 5 | 87a69f9f83b8f0c028a4874acb238f2e079bf51f | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.77e-05 | 180 | 105 | 5 | c12c1cc206f7e63e5722471bd3eb84caddb84129 | |
| ToppCell | IPF-Lymphoid-B|World / Disease state, Lineage and Cell class | 6.77e-05 | 180 | 105 | 5 | 30f9398c9b784f49470847a025bac90687e997a1 | |
| Drug | APETx1, Anthopleura elegantissima | 6.36e-09 | 6 | 105 | 4 | ctd:C475726 | |
| Drug | Zonisamide | 1.12e-08 | 17 | 105 | 5 | DB00909 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 2.95e-08 | 8 | 105 | 4 | ctd:C489827 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 3.80e-07 | 4 | 105 | 3 | ctd:C501880 | |
| Drug | Tetrodotoxin | 1.10e-06 | 40 | 105 | 5 | ctd:D013779 | |
| Drug | fenpropathrin | 1.89e-06 | 6 | 105 | 3 | ctd:C044267 | |
| Drug | Sodium | 2.53e-06 | 84 | 105 | 6 | ctd:D012964 | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.71e-06 | 197 | 105 | 8 | 2326_DN | |
| Drug | Cocaine | 5.25e-06 | 8 | 105 | 3 | DB00907 | |
| Drug | Pirmenolum | 5.90e-06 | 26 | 105 | 4 | CID000004853 | |
| Drug | NSC93767 | 1.39e-05 | 32 | 105 | 4 | CID000005658 | |
| Drug | flecainide | 1.94e-05 | 71 | 105 | 5 | CID000003355 | |
| Drug | benzocaine | 2.51e-05 | 37 | 105 | 4 | CID000002337 | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A | 3.29e-05 | 194 | 105 | 7 | 4524_DN | |
| Drug | PF-01378883-00 [351320-41-7]; Up 200; 10uM; PC3; HT_HG-U133A | 3.87e-05 | 199 | 105 | 7 | 6410_UP | |
| Drug | Folic acid [59-30-3]; Up 200; 9uM; HL60; HG-U133A | 3.87e-05 | 199 | 105 | 7 | 1790_UP | |
| Drug | AC1OAGFB | ROCK2 BLNK HIP1R ARHGAP35 CHRM2 RPH3A PIK3CD SCN3A SCN9A SCN10A EXOC7 | 3.96e-05 | 539 | 105 | 11 | CID006857345 |
| Drug | Melphalan | 4.26e-05 | 276 | 105 | 8 | ctd:D008558 | |
| Drug | pilsicainide | 6.00e-05 | 46 | 105 | 4 | CID000004820 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 6.30e-05 | 3 | 105 | 2 | ctd:C561228 | |
| Drug | Scorpion Venoms | 7.39e-05 | 18 | 105 | 3 | ctd:D012604 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 6.11e-16 | 10 | 103 | 7 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 6.11e-16 | 10 | 103 | 7 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 4.01e-15 | 12 | 103 | 7 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 3.80e-08 | 93 | 103 | 7 | C1535926 | |
| Disease | Primary Erythermalgia | 4.13e-08 | 3 | 103 | 3 | C0014805 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 4.13e-08 | 3 | 103 | 3 | C1833661 | |
| Disease | Epilepsy | 1.14e-07 | 109 | 103 | 7 | C0014544 | |
| Disease | Epilepsy, Cryptogenic | 4.41e-07 | 82 | 103 | 6 | C0086237 | |
| Disease | Awakening Epilepsy | 4.41e-07 | 82 | 103 | 6 | C0751111 | |
| Disease | Aura | 4.41e-07 | 82 | 103 | 6 | C0236018 | |
| Disease | anxiety disorder (implicated_via_orthology) | 9.76e-07 | 22 | 103 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Congenital Pain Insensitivity | 1.43e-06 | 7 | 103 | 3 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1.43e-06 | 7 | 103 | 3 | C0020075 | |
| Disease | epilepsy (implicated_via_orthology) | 1.75e-06 | 163 | 103 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 3.42e-06 | 9 | 103 | 3 | C3502809 | |
| Disease | Myoclonic Astatic Epilepsy | 6.68e-06 | 11 | 103 | 3 | C0393702 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.15e-05 | 13 | 103 | 3 | C0751122 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 1.21e-05 | 2 | 103 | 2 | C4551549 | |
| Disease | Intellectual Disability | 2.77e-05 | 447 | 103 | 9 | C3714756 | |
| Disease | B Virus Infection | 3.61e-05 | 3 | 103 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 3.61e-05 | 3 | 103 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 3.61e-05 | 3 | 103 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 3.61e-05 | 3 | 103 | 2 | C0019372 | |
| Disease | alcohol consumption measurement | ANKS1B BRD3 CHRM2 RPH3A KCNC1 PRCC SETBP1 ARID5B SCN8A COBL ASXL2 PEAK1 PRDM16 TET3 | 1.06e-04 | 1242 | 103 | 14 | EFO_0007878 |
| Disease | Profound Mental Retardation | 1.30e-04 | 139 | 103 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.30e-04 | 139 | 103 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.30e-04 | 139 | 103 | 5 | C0917816 | |
| Disease | Lennox-Gastaut syndrome | 1.79e-04 | 6 | 103 | 2 | C0238111 | |
| Disease | Familial benign neonatal epilepsy | 1.79e-04 | 6 | 103 | 2 | C0220669 | |
| Disease | Autism spectrum disorder | 2.51e-04 | 7 | 103 | 2 | cv:C1510586 | |
| Disease | Seizure, Febrile, Simple | 2.51e-04 | 7 | 103 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 2.51e-04 | 7 | 103 | 2 | C0751057 | |
| Disease | squamous cell lung carcinoma | 2.90e-04 | 165 | 103 | 5 | EFO_0000708 | |
| Disease | atrial fibrillation | 3.31e-04 | 371 | 103 | 7 | EFO_0000275 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 3.33e-04 | 8 | 103 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 3.33e-04 | 8 | 103 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 3.33e-04 | 8 | 103 | 2 | C0338479 | |
| Disease | Autistic behavior | 3.33e-04 | 8 | 103 | 2 | C0856975 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 3.33e-04 | 8 | 103 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 3.33e-04 | 8 | 103 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 3.33e-04 | 8 | 103 | 2 | C0393703 | |
| Disease | Febrile Convulsions | 4.28e-04 | 9 | 103 | 2 | C0009952 | |
| Disease | Myoclonic Epilepsy | 4.28e-04 | 9 | 103 | 2 | C0014550 | |
| Disease | QRS complex, QRS duration | 5.27e-04 | 45 | 103 | 3 | EFO_0005054, EFO_0005055 | |
| Disease | Epilepsy, Myoclonic, Infantile | 5.33e-04 | 10 | 103 | 2 | C0917800 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 7.19e-04 | 50 | 103 | 3 | C0023453 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 8.06e-04 | 52 | 103 | 3 | C0023452 | |
| Disease | Metastatic melanoma | 9.00e-04 | 54 | 103 | 3 | C0278883 | |
| Disease | Respiratory Depression | 9.18e-04 | 13 | 103 | 2 | C0235063 | |
| Disease | Respiratory Insufficiency | 9.18e-04 | 13 | 103 | 2 | C0035229 | |
| Disease | Respiratory Failure | 9.18e-04 | 13 | 103 | 2 | C1145670 | |
| Disease | blood urea nitrogen measurement | 1.06e-03 | 452 | 103 | 7 | EFO_0004741 | |
| Disease | osteoarthritis | 1.11e-03 | 222 | 103 | 5 | MONDO_0005178 | |
| Disease | vitamin D measurement | 1.18e-03 | 336 | 103 | 6 | EFO_0004631 | |
| Disease | MMR-related febrile seizures | 1.23e-03 | 15 | 103 | 2 | EFO_0006519 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1.28e-03 | 61 | 103 | 3 | C1961102 | |
| Disease | Neuralgia, Supraorbital | 1.40e-03 | 16 | 103 | 2 | C0038870 | |
| Disease | Neuralgia | 1.40e-03 | 16 | 103 | 2 | C0027796 | |
| Disease | Neuralgia, Atypical | 1.40e-03 | 16 | 103 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 1.40e-03 | 16 | 103 | 2 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 1.40e-03 | 16 | 103 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 1.40e-03 | 16 | 103 | 2 | C0423711 | |
| Disease | Paroxysmal Nerve Pain | 1.40e-03 | 16 | 103 | 2 | C0751373 | |
| Disease | Nerve Pain | 1.40e-03 | 16 | 103 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 1.40e-03 | 16 | 103 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 1.40e-03 | 16 | 103 | 2 | C0042656 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 1.40e-03 | 16 | 103 | 2 | C0393706 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 1.59e-03 | 17 | 103 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 1.59e-03 | 17 | 103 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 1.59e-03 | 17 | 103 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 1.59e-03 | 17 | 103 | 2 | C0751780 | |
| Disease | May-White Syndrome | 1.59e-03 | 17 | 103 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 1.59e-03 | 17 | 103 | 2 | C0751781 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 1.78e-03 | 18 | 103 | 2 | HP_0002373 | |
| Disease | Myeloid Leukemia | 1.78e-03 | 18 | 103 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 1.78e-03 | 18 | 103 | 2 | C0023466 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 1.78e-03 | 18 | 103 | 2 | C0751779 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 1.98e-03 | 801 | 103 | 9 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.02e-03 | 152 | 103 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Paroxysmal atrial fibrillation | 2.21e-03 | 156 | 103 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 2.21e-03 | 156 | 103 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.21e-03 | 156 | 103 | 4 | C2585653 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 2.43e-03 | 21 | 103 | 2 | C1292769 | |
| Disease | Atrial Fibrillation | 2.43e-03 | 160 | 103 | 4 | C0004238 | |
| Disease | insulin measurement | 2.49e-03 | 267 | 103 | 5 | EFO_0004467 | |
| Disease | obsolete_red blood cell distribution width | ADAD1 ABL1 CARMIL1 HIP1R BRD3 AK9 ZNF217 ZFAND4 HP1BP3 NKD2 ASXL2 CDCA5 | 2.58e-03 | 1347 | 103 | 12 | EFO_0005192 |
| Disease | acute myeloid leukemia (is_implicated_in) | 3.21e-03 | 84 | 103 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | Leukemia, Myelocytic, Acute | 3.21e-03 | 173 | 103 | 4 | C0023467 | |
| Disease | Autism Spectrum Disorders | 3.32e-03 | 85 | 103 | 3 | C1510586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RTTEPKQPVEPKKPV | 66 | Q13569 | |
| PPTPPVVKKKGVKRK | 231 | Q15059 | |
| PKPAALPKPGKRLKQ | 201 | Q5SNV9 | |
| PGISPPPEKQKRKKK | 206 | Q96FF9 | |
| PQVPQPVPIRKAKTK | 231 | Q8TDI0 | |
| EPRTNLKLPKPPKKV | 446 | O00481 | |
| SISNPVLPPKKIPKE | 71 | Q96M93 | |
| QPAKKKPPPSREKKV | 371 | P08172 | |
| PKSKPKKPRPKSVHR | 1361 | Q5T5Y3 | |
| SKPKSPGVEKPIVKP | 526 | Q76L83 | |
| PRPPKRATKPKKAPK | 76 | Q8N436 | |
| PPPKRRLQKKTPAKS | 451 | Q5SSJ5 | |
| PKRGTEPKVKLPPKS | 286 | Q15113 | |
| ENKPSKPIPKPRVSI | 1206 | Q7Z6G8 | |
| QKKKRKVEPPTPQEP | 156 | Q6WCQ1 | |
| LTQPKKDEPKKLPPR | 86 | P43026 | |
| AAKRPAKVQKPPPKP | 176 | Q8IZA3 | |
| IKPVKPIKAKPQYKP | 311 | Q96JE9 | |
| NISLKKAKKPPLPPS | 666 | Q5SYE7 | |
| FRPPVAKKPTIAVKP | 61 | Q9H792 | |
| IKKKKPGPRVEGPPQ | 266 | Q96HM7 | |
| EACKKITKPPRPKPA | 61 | Q9H1M4 | |
| PRPKGPEKQFLKSPK | 321 | Q969F2 | |
| PQITPPPVMILKKKR | 171 | P09884 | |
| PAIPNKRKDTPTKKP | 251 | Q9UPT5 | |
| PTKKPVKRPGTIRKA | 261 | Q9UPT5 | |
| KKKPPSPIKPKIPLS | 236 | P12034 | |
| MQPPPRKVKPAQEVK | 1 | Q86WN1 | |
| PIVSIPKAGRKPKIQ | 1191 | Q92794 | |
| KKPPLAQKPSVAPRQ | 1036 | O75146 | |
| KLPKKKKKHIPRPPQ | 451 | P48547 | |
| IKKLKVKAPPSVPRR | 36 | Q8WV28 | |
| QPRKKQPPTAVPKEM | 36 | Q9P2K1 | |
| PRASKPPKLPKLPKK | 166 | Q96LM5 | |
| LRKKQPKKPVPEILP | 11 | Q13698 | |
| VPKPRVKKQPKTQRG | 186 | O14647 | |
| KLPKANIPVRPKPSF | 501 | Q86XJ1 | |
| CPENLLPPKKIKTPK | 76 | Q5T1B0 | |
| LPPKKIKTPKGTLPR | 81 | Q5T1B0 | |
| KPSPEVKIPTQRKPI | 2121 | Q8N3K9 | |
| PKKKFKPVVQRPVPK | 1091 | O75128 | |
| LRIVKPPKLPLEKKP | 26 | Q6PIV2 | |
| KRGPKPKPLVVQVPT | 71 | O00257 | |
| KKPVLPATPKPQSAK | 956 | P00519 | |
| KQEPVKPAVLAKPPV | 71 | Q8TC76 | |
| APPIKPIKPVTRNKA | 1126 | Q03164 | |
| KVAPRPSIPVKQKPK | 1346 | Q03164 | |
| QPPLMKKIIPAPKPK | 1816 | Q03164 | |
| PGPTKPKPKTKRFQL | 3531 | Q03164 | |
| VPPKTVEPLTVKQKP | 221 | Q8N7W2 | |
| SPKVALLPPVLKKVP | 1291 | Q5VZK9 | |
| KKPPQKRPLKQPSHN | 131 | Q9NRM1 | |
| SRKKKPDSPPKVLEP | 741 | Q96T23 | |
| PKKNPVPLKQTVQPK | 1366 | Q13029 | |
| NPPPAEKTVKKKRPP | 756 | Q9HAU5 | |
| SRREQKPPKKPKSPK | 166 | P51608 | |
| FHRPPAKPKPQKVKE | 291 | Q4G0U5 | |
| PVAKPGPVKTLTRKK | 16 | Q9GZR2 | |
| PIPPRVAKKAIRKLK | 231 | Q5HYW3 | |
| NPIKYIRQPKPKPTV | 1396 | Q5TCS8 | |
| FPKQVLPQPMPIKKT | 161 | Q9Y2J0 | |
| IKKLIPNPNKIRKPP | 261 | P78345 | |
| PNPNKIRKPPKSKKA | 266 | P78345 | |
| PEPVKKPPKEQRSIK | 121 | Q96BD8 | |
| PKPKKRKEPVKIAAP | 136 | Q92733 | |
| VPPKPKDQRSIIKTP | 641 | Q9NYJ8 | |
| KKGKIPPPVPKKPSV | 996 | Q5HYW2 | |
| KSPRIQAKPKPKPNQ | 701 | Q8N3V7 | |
| PKQQLPPKKKRRVGT | 1346 | P21675 | |
| TTKPKDVKPILPMPK | 776 | Q9HAZ2 | |
| KKLGSKKPQKPIPRP | 1486 | Q15858 | |
| KKPQKPIPRPGNKIQ | 1491 | Q15858 | |
| SKKPQKPIPRPANKF | 1501 | Q9NY46 | |
| KVESKPKVPLKSAPP | 151 | Q68D10 | |
| SLRRNTKKPKPKPRP | 1221 | Q9NRY4 | |
| NRTKKKPTPKPPVVD | 206 | Q92954 | |
| KPKTMPRVRKPKTTP | 1036 | Q92954 | |
| HKKKRVVPKKPPPSP | 516 | Q13438 | |
| KVPRSRKQPPPKESK | 46 | Q8N5C6 | |
| SKKPQKPIPRPGNKF | 1516 | P35498 | |
| ENKSRKKKPPVSPPL | 456 | Q8IY92 | |
| VPPKPKMKPIIHKSN | 1546 | Q9UPX8 | |
| PNLKGRPRKKKPCPQ | 246 | Q14865 | |
| QPRKKSPPVKAVPIQ | 541 | Q99941 | |
| IARKPAKPQPKLKPK | 241 | Q7Z739 | |
| KKQKSLEPSIPPPRI | 1841 | Q86UP3 | |
| KRPPKTTPVAKHPKK | 66 | Q9UJ98 | |
| SKKPQKPIPRPLNKF | 1451 | Q9Y5Y9 | |
| IKPLIPKPKPKQASA | 961 | O75717 | |
| PAPKPASPKKNIKTR | 321 | Q6FHJ7 | |
| LPAPETPRKKTPIQK | 836 | Q96GP6 | |
| TPRKKTPIQKPPRKK | 841 | Q96GP6 | |
| VKPKRSKGEPPKTVP | 241 | O15391 | |
| SKKPQKPIPRPANKF | 1506 | Q99250 | |
| KVIKEKVPPRPILKQ | 741 | P53804 | |
| VQKPRAKPPPIPAKK | 296 | O00329 | |
| VSRLVKKIPKKPPAP | 1341 | O75116 | |
| PLKKKPTPVLLPQSK | 531 | Q9UGP8 | |
| GSKKPQKPIPRPLNK | 1496 | Q9UQD0 | |
| ENPPPTKKIGKKPVA | 2281 | O95359 | |
| APGIKPSVRKPIQIK | 596 | O43151 | |
| SKPKERPAIPPKLSK | 536 | Q86YV5 | |
| VPQRKLKPPIVPKIA | 311 | P51817 | |
| KSRISKKPQVPKKPR | 66 | O15213 | |
| KKPQVPKKPREWKNP | 71 | O15213 | |
| TPPVPPKKVTAAEKK | 1161 | Q6ZT12 | |
| PKPQKPKTKIPKVVN | 256 | Q8N567 | |
| ISDKPNKVIIPSPPK | 1736 | Q96JM2 | |
| PDKTKRPETKLKPLP | 851 | O75362 | |
| SKKPQKPIPRPLNKC | 1341 | Q9UI33 | |
| PKVSSPTKPKKIRQP | 216 | Q8WUA4 | |
| QEKSPVKTVPRAKPP | 441 | Q5VWN6 | |
| VKTVPRAKPPVKKSP | 446 | Q5VWN6 | |
| RAKPPVKKSPQKQRV | 451 | Q5VWN6 | |
| KKAVKIKPHPPVAPR | 241 | Q86XD8 | |
| TPVKKKRGRPKKQPL | 581 | Q9Y6X0 | |
| IPPPKRPLKVSQKIS | 1671 | Q69YN4 | |
| RPLPVKPKTKVKQRV | 436 | Q9BWF2 |